No effect of norepinephrine dose on anti-Xa activity in critically ill patients

S.D. Meenks, N.A. Foudraine, K. Broen, J.L.M.L. le Noble, P.K.C. Janssen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)223-229
Number of pages7
JournalInternational Journal of Clinical Pharmacology and Therapeutics
Volume58
Issue number4
DOIs
Publication statusPublished - 1 Apr 2020

Keywords

  • dalteparin
  • intensive care unit
  • lmwh
  • molecular-weight heparins
  • vasopressor therapy
  • venous thromboembolism
  • vte prophylaxis
  • LMWH
  • VTE prophylaxis
  • MOLECULAR-WEIGHT HEPARINS

Cite this